BIOSW Stock Price, Chart, Stats & News

BioPlus Acquisition Corp.
Save
209.07M
Market cap
–
Current P/E
–
Forward P/E
BIOSW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -158.67% |
ROA | 2.17% |
ROE | 2.33% |
D/E | 0.02x |
Interest coverage ratio | – |
BIOSW valuation
P/E | – |
P/S | – |
P/B | 28.94x |
P/CF | -9332.60x |
P/FCF | -302.36x |
P/OCF | -9332.60x |
PEG | 12.50x |
EV multiple | -174.39x |
About
BioPlus Acquisition Corp. was established with the core objective of entering into a business combination, which may take various forms including a merger, share exchange, asset acquisition, stock purchase, or corporate reorganization, with one or more entities. The firm intends to concentrate its search for suitable partners exclusively within the life sciences industry. This company commenced operations in 2021 and is headquartered in New York, New York.
Similar securities
Based on sector and market capitalization
Report issue











